Taro pharma appoints new CFO

Taro Pharmaceutical Industries Ltd. announced the appointment of Daphne Huang as Vice President, CFO and Chief Accounting Officer, effective today.

Huang has over 20 years of senior executive experience in finance; most recently serving as Chief Financial Officer at Humanwell Healthcare USA & Puracap International, having financial oversight of their generic pharmaceutical and OTC portfolios.

Prior to Humanwell, Huang held progressively responsible positions in the financial service sector and debt capital markets working for companies such as PriceWaterhouseCoopers, FleetBoston, GE Capital and HSBC.

Regarding the appointment, Uday Baldota, Taro’s CEO, commented, “We are very pleased to have Daphne join the Taro team. Her diversified financial background will further strengthen our management team and contribute to the continuing growth and expansion of our business.”

Huang earned an MBA in Finance and Management from the Leonard N. Stern School of Business at New York University, and a BBA in Accounting from Baruch College.

Earlier in December, Taro Pharmaceutical Industries accepted the resignation of Mariano Balaguer, company’s former CFO. 

Website | + posts

HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.

What's your take on this post ? Comment: